In 1999 the research
group moved to the New
Synthetic Building
which provides an excellent new working environment. Work in the
group has
been funded by a varitey of sources including GSK, AstraZeneca, Merck,
Pfizer, the DTI and, most recently, HEFCE.
Contact
Details
Secretaries
Dr Paul Wyatt Organic
& Biological Chemistry Section School
of Chemistry University
of Bristol Cantock's
Close Bristol,
BS8 1TS